These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28213762)

  • 21. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease.
    Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K
    Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?
    Merola A; Romagnolo A; Rosso M; Lopez-Castellanos JR; Wissel BD; Larkin S; Bernardini A; Zibetti M; Maule S; Lopiano L; Espay AJ
    Parkinsonism Relat Disord; 2016 Dec; 33():65-71. PubMed ID: 27641792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuropsychological impairment in Parkinson's disease without dementia].
    Marañón D; Amayra I; Uterga JM; Gómez-Esteban JC
    Psicothema; 2011 Nov; 23(4):732-7. PubMed ID: 22047866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
    Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.
    Fengler S; Roeske S; Heber I; Reetz K; Schulz JB; Riedel O; Wittchen HU; Storch A; Linse K; Baudrexel S; Hilker R; Mollenhauer B; Witt K; Schmidt N; Balzer-Geldsetzer M; Dams J; Dodel R; Gräber S; Pilotto A; Petrelli A; Fünkele S; Kassubek J; Kalbe E
    Psychol Med; 2016 Aug; 46(11):2275-86. PubMed ID: 27193073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.
    Brennan L; Siderowf A; Rubright JD; Rick J; Dahodwala N; Duda JE; Hurtig H; Stern M; Xie SX; Rennert L; Karlawish J; Shea JA; Trojanowski JQ; Weintraub D
    Parkinsonism Relat Disord; 2016 Apr; 25():21-6. PubMed ID: 26923524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.
    Brennan L; Siderowf A; Rubright JD; Rick J; Dahodwala N; Duda JE; Hurtig H; Stern M; Xie SX; Rennert L; Karlawish J; Shea JA; Trojanowski JQ; Weintraub D
    Mov Disord; 2016 Jan; 31(1):126-34. PubMed ID: 26249849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.
    Ruzafa-Valiente E; Fernández-Bobadilla R; García-Sánchez C; Pagonabarraga J; Martínez-Horta S; Kulisevsky J
    J Neurol Sci; 2016 Feb; 361():66-71. PubMed ID: 26810519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
    Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
    Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study.
    Amboni M; Iuppariello L; Iavarone A; Fasano A; Palladino R; Rucco R; Picillo M; Lista I; Varriale P; Vitale C; Cesarelli M; Sorrentino G; Barone P
    J Neurol; 2018 Oct; 265(10):2211-2220. PubMed ID: 30014240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Memory for spatial location is affected in Parkinson's disease.
    Pillon B; Ertle S; Deweer B; Sarazin M; Agid Y; Dubois B
    Neuropsychologia; 1996 Jan; 34(1):77-85. PubMed ID: 8852695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motor loop dysfunction causes impaired cognitive sequencing in patients suffering from Parkinson's disease.
    Schönberger AR; Hagelweide K; Pelzer EA; Fink GR; Schubotz RI
    Neuropsychologia; 2015 Oct; 77():409-20. PubMed ID: 26382750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
    Verleden S; Vingerhoets G; Santens P
    Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal study of normal cognition in Parkinson disease.
    Pigott K; Rick J; Xie SX; Hurtig H; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Akhtar RS; Siderowf A; Trojanowski JQ; Weintraub D
    Neurology; 2015 Oct; 85(15):1276-82. PubMed ID: 26362285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.